Delivery Order SPE2DB22D1106-SPE2DB24FEPE7
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, by the U.S. Department of Defense (DoD) Medical Supply Chain. The contract, valued at $15,929.84, is for the delivery of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a prescription medication. This is a firm-fixed-price delivery order contract with a completion date of May 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the Defense...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $11,734.62, is for the delivery of GONAL-F RFF REDI-JECT 450 UNIT 0.75ML medical supplies. It is a firm fixed-price delivery order contract with a completion date of February 4, 2025. The contract is not designated with any set-aside requirements, indicating open competition....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,950.00, is for the delivery of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 26, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,852.82 firm fixed-price contract is for the supply of GONAL-F RFF REDI-JECT 300 UNIT 0.5ML, a prescription medication. The contract has an ultimate completion date of March 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award is a delivery order (SPE2DX15D3012|SPE2DX24F8PD8) issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,039.62 firm fixed-price contract is for the delivery of 4,564,714,409 units of the pharmaceutical product GONAL-F RFF REDI-JECT 900 UNIT 1.5ML. This contract does not have a set-aside designation and has an ultimate completion date of May 28, 2024. Amerisourcebergen Drug...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a pharmaceutical product, with a ceiling value of $136,146.74 and a period of performance through January 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, suggesting open competition....
- This is a $16,462.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides GONAL-F RFF REDI-JECT 450 UNIT 0.75ML medical supplies with a period of performance through February 2025. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,594 delivery order contract is for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML medical products. The contract has a firm fixed price and is set to expire on November 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $76,965.58 award is for the provision of 4,564,016,451 units of the pharmaceutical product GONAL-F RFF REDI-JECT 900 (1.5 ML). This delivery order falls under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to AmerisourceBergen Drug Corp, which serves as the primary...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GONAL-F RFF REDI-JECT 450 UNIT 0.75ML, a pharmaceutical product, with a ceiling value of $1,097.48 and a period of performance through June 26, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition....
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEPE7Delivery Order
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,564,437,307 units of the medication "GONAL-F RFF REDI-JECT 900 UNIT 1.5ML" with a ceiling value of $15,276.64. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific award is not designated as a set-aside contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.3k | 4/29/24 |